Qanatpharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
410 Adelaide St W 220, Toronto, Ontario,...Website
www.qanatpharma.comRevenue
<$5 MillionIndustry
About Qanatpharma
Qanatpharma Org Chart
Senior Scientist - Molecular Discovery
Is Qanatpharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Qanatpharma is spiking on competitors!
Check if Qanatpharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Qanatpharma recently announced quarterly report
Funding: Get notified immidiatlly once Qanatpharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Qanatpharma
Qanatpharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Qanatpharma launches new products
Click to see if Qanatpharma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Qanatpharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Qanatpharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Qanatpharma.
Qanatpharma Tech Stack
A closer look at the technologies used by Qanatpharma
Qanatpharma News & Media
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Qanatpharma
Qanatpharma is a clinical-stage biopharma company focused on microvascular research and medicine, developing therapeutic strategies to address microvascular dysfunction associated with various diseases. Their pipeline includes innovative research utilizing transcriptomic/proteomic approaches and AI/machine-learning strategies to enhance drug identi... Read More